On July 13, 2010
Glaxo CEO Worried in Email Over Heart Attacks From Avandia — in 1999
GlaxoSmithKline (GSK)’s decision to settle most of the litigation over its Avandia for $460 million means that former CEO Jean-Pierre Garnier will never testify about why he sent an email in 1999 raising concerns that his diabetes drug had “a
…
0 Comments